President Donald Trump has directed the Food and Drug Administration (FDA) to ramp up its efforts to ensure that advertising of prescription drugs directed to consumers is transparent and accurate.
That includes requiring drug makers to provide more information on the risks of using the drug, and stepping up enforcement of federal laws regulating these ads.